OraPharma is a specialty pharmaceutical company that develops and commercializes products that help improve and maintain oral health.
OraPharma is a specialty pharmaceutical company that develops and commercializes products that help improve and maintain oral health. They are dedicated to delivering scientifically and technologically advanced products to dental professionals and their practices.ARESTIN® (minocycline HCl) Microspheres, 1 mg is a locally administered antibiotic (LAA) offering a patented microsphere technology. OraPharma is proud to have introduced this revolutionary approach to treating periodontitis as an adjunct to scaling and root planing and continues to take a leadership role in educating clinicians and consumers on the disease. Read more about ARESTIN® or click here for Prescribing Information.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 14, 1998 | Series Unknown | $16M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Senmed Medical Ventures | — | Series Unknown |
Biotechnology Investments | — | Series Unknown |